Literature DB >> 12116008

Prevalence and genotype distribution of cervical human papillomavirus infection: Comparison between pregnant women and non-pregnant controls.

Paul K S Chan1, Alexander R Chang, Wing-Hung Tam, Jo L K Cheung, Augustine F Cheng.   

Abstract

Controversies exist on the effect of pregnancy on human papillomavirus (HPV) infection. A cross-sectional section study was conducted to compare the prevalence and genotype distribution of cervical HPV infection between pregnant and non-pregnant women in Hong Kong. Cervical samples were collected from 308 pregnant women and from the same number of age-matched controls recruited from a cervical cancer screening center located at the same hospital. HPV was detected by the polymerase chain reaction, followed by genotype identification by restriction fragment length polymorphism and direct sequencing analyses. The prevalence of HPV for pregnant women was 10.1%, without significant variation with age, gestation, gravidity and parity. The prevalence of HPV for non-pregnant group was 11.4% and did not show significant difference when compared to the pregnant group either by overall or age-stratified subgroup analyses. When the analysis was stratified according to the risk-type of HPV infection, still no significant difference between pregnant and non-pregnant groups was observed (all types: 10.1 vs. 11.4%, P = 0.602; high-risk types: 5.8 vs. 7.8%, P = 0.338; low-risk types: 1.0 vs. 2.9%, P = 0.080; unknown-risk types: 3.2% vs. 1.3%, P = 0.105). The results of this study show no evidence for an influence of pregnancy on HPV prevalence, and a majority of HPV-infected pregnant women had normal cervical cytology. HPV positive results in pregnant women per se should be managed conservatively. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12116008     DOI: 10.1002/jmv.10142

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  10 in total

1.  Demystifying animal models of adverse pregnancy outcomes: touching bench and bedside.

Authors:  Elizabeth A Bonney
Journal:  Am J Reprod Immunol       Date:  2013-02-28       Impact factor: 3.886

2.  Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  Lynne M Mofenson; Michael T Brady; Susie P Danner; Kenneth L Dominguez; Rohan Hazra; Edward Handelsman; Peter Havens; Steve Nesheim; Jennifer S Read; Leslie Serchuck; Russell Van Dyke
Journal:  MMWR Recomm Rep       Date:  2009-09-04

Review 3.  Human Papillomavirus Infection as a Possible Cause of Spontaneous Abortion and Spontaneous Preterm Delivery.

Authors:  Lea Maria Margareta Ambühl; Ulrik Baandrup; Karen Dybkær; Jan Blaakær; Niels Uldbjerg; Suzette Sørensen
Journal:  Infect Dis Obstet Gynecol       Date:  2016-03-27

4.  Human papillomavirus as a single infection in pregnant women from Northeastern Mexico: Cross-sectional study.

Authors:  Bernardo Martínez-Leal; Karla Ivette Álvarez-Banderas; Homero Sánchez-Dávila; Martha Imelda Dávila-Rodríguez; Elva Irene Cortés-Gutiérrez
Journal:  Int J Reprod Biomed       Date:  2020-02-27

5.  Detection of high-risk human papillomavirus (HPV) by the novel AmpFire isothermal HPV assay among pregnant women in Pemba Island, Tanzania.

Authors:  Naomi Christine Angela Juliana; Mohamed Hamad Juma; Roel Heijmans; Sander Ouburg; Said Mohammed Ali; Aishwarya Singh Chauhan; Amanhi Biobank Pemba; Sunil Sazawal; Servaas Antonie Morré; Saikat Deb; Elena Ambrosino
Journal:  Pan Afr Med J       Date:  2020-10-27

6.  Human Papillomavirus (HPV) infection in pregnant women and mother-to-child transmission of genital HPV genotypes: a prospective study in Spain.

Authors:  Xavier Castellsagué; Teresa Drudis; Maria Paz Cañadas; Anna Goncé; Ramón Ros; José M Pérez; M Jesús Quintana; Jesús Muñoz; Ginesa Albero; Silvia de Sanjosé; F Xavier Bosch
Journal:  BMC Infect Dis       Date:  2009-05-27       Impact factor: 3.090

Review 7.  The prevalence and risk of human papillomavirus infection in pregnant women.

Authors:  P Liu; L Xu; Y Sun; Z Wang
Journal:  Epidemiol Infect       Date:  2014-03-25       Impact factor: 4.434

8.  Risk of Human Papillomavirus (HPV) Infection and Cervical Neoplasia after Pregnancy.

Authors:  Helen Trottier; Marie-Hélène Mayrand; Maria Luiza Baggio; Lenice Galan; Alex Ferenczy; Luisa L Villa; Eduardo L Franco
Journal:  BMC Pregnancy Childbirth       Date:  2015-10-07       Impact factor: 3.007

9.  Factors influencing adolescent girls' decision in initiation for human papillomavirus vaccination: a cross-sectional study in Hong Kong.

Authors:  Albert Lee; Mandy Ho; Calvin Ka Man Cheung; Vera Mei Wen Keung
Journal:  BMC Public Health       Date:  2014-09-08       Impact factor: 3.295

10.  Prevalence and Incidence of Human Papillomavirus (HPV) Infection Before and After Pregnancy: Pooled Analysis of the Control Arms of Efficacy Trials of HPV-16/18 AS04-Adjuvanted Vaccine.

Authors:  Jing Chen; Kusuma Gopala; P K Akarsh; Frank Struyf; Dominique Rosillon
Journal:  Open Forum Infect Dis       Date:  2019-12-04       Impact factor: 3.835

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.